Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Glucose-TOR-PDCB signaling restricts cell-to-cell communication through callose deposition.

Created on 05 Sep 2026

Authors

Michael Busche, Anne M Runkel, Min Xu, Katherine A Klimpel, Sannidhi Menon, Katherine M Lund, Kyle Koch, Snigdha Chatterjee, Erin R Alberts, Ryan E Martinez, M Regina Scarpin, Jacob O Brunkard

Published in

Science advances. Volume 12. Issue 36. Pages eaeg9566. Sep 04, 2026. Epub Sep 04, 2026.

Abstract

Plant cells are connected by plasmodesmata (PD), membrane-lined channels that facilitate cell-to-cell transport. Forward genetic screens to uncover regulators of PD transport identified mutants with increased (ise1 to ise4) or decreased (dse1) PD trafficking during embryogenesis. Despite their opposite effects on PD transport, we found that the transcriptional profiles of dse1, ise3, and ise4 were notably similar with one notable exception: the set of genes controlled by the conserved kinase TARGET OF RAPAMYCIN (TOR) and ABI5, a bZIP transcription factor that acts downstream of TOR. We then showed that the glucose-TOR-ABI5 signaling axis regulates PD transport by driving expression of PD-localized callose binding proteins (PDCBs), which are oppositely regulated in ise versus dse mutants and promote callose deposition at PD. Together, this study establishes a mechanism for metabolic regulation of cell-to-cell transport by TOR-ABI5-PDCB signaling.

PMID:
42696584
Bibliographic data and abstract were imported from PubMed on 05 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement